# X-Magtech

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/x-magtech

- Industry: Medical Devices & Equipment
- Headquarters: Beijing, China
- Website: www.xmagtech.com
- Total disclosed funding: $29M
- Latest round: Series B (Jun 4, 2026)
- Investors on record: 11

## About

Founded in 2020 and based in Beijing, China , Beijing X-Magtech Technologies Co., Ltd, trading as X-Magtech, is a provider of medical devices for weak magnetic field measurement that focuses on creating medical equipment for bio-magnetic field imaging.It has received over CNY 200 million in financing in the past two years, and has been recognised as a Specialized, Refined, Featured and Original SME in Beijing. The core team graduated from Tsinghua University and Nanjing University and has more than 15 years of experience in metrology, quantum physics, precision optics, etc. In June 2026, it closed a series B funding. X-Magtech develops and manufactures biomagnetic field imaging medical devices, providing customers with weak magnetic measurement solutions. The products can be divided in two categories which are  cardiac magnetic field and brain magnetic field functional imaging. Its main products include zero-field atomic magnetometer, liquid helium-free magnetoencephalogram, etc. The product can be applied to foetal congenital heart disease screening, early diagnosis of heart disease, brain functional area localisation and other medical tests. X-Magtech generates revenue from the sale of biomagnetic field imaging medical devices and related service fees. The company will use the series B funding to accelerate its research and development of core technologies, large-scale mass production, and industrialization in more application scenarios.

## Funding rounds

- Series B, Jun 4, 2026 — Beijing State-owned Capital Operation and Management, Cornerstone Capital, Casstar Capital, Beijing Industrial Developing Investment Management, Shunxi Fund
- Series A, Jul 22, 2024, $14M — Everest VC, Shougang Fund, Casstar Capital, CMBC International, Y&R Capital, Zhongguancun Science City Capital
- Series A, Jun 9, 2022, $15M — IDG Capital, Everest VC, CMBC International, Y&R Capital, Zhongguancun Science City Capital

## Investors

- IDG Capital (https://capitalatlas.ai/funds/idg-capital) — Series A
- Everest VC (https://capitalatlas.ai/funds/everest-vc) — Series A
- CMBC International — Series A
- Y&R Capital (https://capitalatlas.ai/funds/y-r-capital) — Series A
- Zhongguancun Science City Capital (https://capitalatlas.ai/funds/zhongguancun-science-city-capital) — Series A
- Shougang Fund — Series A
- Casstar Capital (https://capitalatlas.ai/funds/casstar-capital) — Series A, Series B
- Beijing State-owned Capital Operation and Management (https://capitalatlas.ai/funds/beijing-state-owned-capital-operation-and-management) — Series B
- Cornerstone Capital (https://capitalatlas.ai/funds/cornerstone-capital) — Series B
- Beijing Industrial Developing Investment Management (https://capitalatlas.ai/funds/beijing-industrial-developing-investment-management) — Series B
- Shunxi Fund (https://capitalatlas.ai/funds/shunxi-fund) — Series B